Literature DB >> 1910175

Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

B Odermatt1, M Eppler, T P Leist, H Hengartner, R M Zinkernagel.   

Abstract

Virus-induced acquired immune suppression in mice infected with lymphocytic choriomeningitis virus is shown here to be caused by the CD8+-T-cell-dependent elimination of macrophages/antigen-presenting cells. Surprisingly, this is associated with severe destruction of the follicular organization of lymphoid organs, indicating a crucial role for dendritic cells and marginal zone macrophages in maintaining follicular structure. Once established, this immunopathology cannot be readily reversed by the elimination of CD8+ effector cells. Such a T-cell-mediated pathogenesis may play a pivotal role in acquired virus-induced immunosuppression and may represent one strategy by which virus escapes immune surveillance and establishes persistent infections in initially immunocompetent hosts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910175      PMCID: PMC52485          DOI: 10.1073/pnas.88.18.8252

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset.

Authors:  A Tishon; P J Southern; M B Oldstone
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

Review 2.  Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes.

Authors:  P Rácz; K Tenner-Rácz; C Kahl; A C Feller; P Kern; M Dietrich
Journal:  Prog Allergy       Date:  1986

3.  Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo.

Authors:  R Ahmed; C C King; M B Oldstone
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

5.  Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy.

Authors:  K Tenner-Rácz; P Rácz; M Dietrich; P Kern
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

Review 6.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

7.  Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

Authors:  A Fontana; K Frei; S Bodmer; E Hofer; M H Schreier; M A Palladino; R M Zinkernagel
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

8.  Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.

Authors:  E M Fenyö; L Morfeldt-Månson; F Chiodi; B Lind; A von Gegerfelt; J Albert; E Olausson; B Asjö
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells.

Authors:  T P Leist; E Rüedi; R M Zinkernagel
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro.

Authors:  S E Macatonia; P M Taylor; S C Knight; B A Askonas
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  75 in total

1.  Viral persistence in vivo through selection of neutralizing antibody-escape variants.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B M Senn; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Authors:  Brian M Sullivan; Sébastien F Emonet; Megan J Welch; Andrew M Lee; Kevin P Campbell; Juan C de la Torre; Michael B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-26       Impact factor: 11.205

3.  Viral immunosuppression: disabling the guards.

Authors:  Marco Colonna
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 4.  Immunological memory ≠ protective immunity.

Authors:  Rolf M Zinkernagel
Journal:  Cell Mol Life Sci       Date:  2012-04-06       Impact factor: 9.261

Review 5.  Apoptosis and the homeostatic control of immune responses.

Authors:  David Hildeman; Trine Jorgensen; John Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2007-07-20       Impact factor: 7.486

6.  Dynamics of Lymphocyte Reconstitution After Hematopoietic Transplantation During Chronic Lymphocytic Choriomeningitis Virus Infection.

Authors:  Mitra Bhattacharyya; Pablo Penaloza-MacMaster
Journal:  AIDS Res Hum Retroviruses       Date:  2018-04-18       Impact factor: 2.205

Review 7.  The role of germinal centers for antiviral B cell responses.

Authors:  M F Bachmann
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

8.  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Sara E J Cotterell; Tracey L Mynott; Asiya Tschannerl; Patricia M A Gorak-Stolinska; Paul M Kaye
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Lymph Node Stromal Fiber ER-TR7 Modulates CD4+ T Cell Lymph Node Trafficking and Transplant Tolerance.

Authors:  Bryna E Burrell; Kristi J Warren; Yumi Nakayama; Daiki Iwami; C Colin Brinkman; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

10.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection.

Authors:  Scott N Mueller; Mehrdad Matloubian; Daniel M Clemens; Arlene H Sharpe; Gordon J Freeman; Shivaprakash Gangappa; Christian P Larsen; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.